Dr. Onat Kadioglu

Dr. Onat Kadioglu
Institute of Pharmacy, Pharmaceutical Biology Department
Staudinger Weg 5
Web page

Research Interests

Molecular biology, Cancer biology, Bioinformatics

Key techniques: Cell culture techniques, Molecular biology techniques, Bioinformatics tools

Research system/organism: in silico, in vitro, human cancer cell line cultures, bacterial cultures

Five Most Relevant Publications
  1. Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses. Front Pharmacol. 2018 Apr 16;9:355
  2. Artemisinin Derivatives Target Topoisomerase 1 and Cause DNA Damage in Silico and in Vitro. Front Pharmacol. 2017 Oct 9;8:711
  3. Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance. Sci Rep. 2016 Nov 8;6:36754
  4. Synthetic cajanin stilbene acid derivatives inhibit c-MYC in breast cancer cells. Archives of Toxicology, 2015 Feb 26. DOI 10.1007/s00204-015-1480-2.
  5. Pharmacogenomics of Cantharidin in Tumor Cells. Biochem Pharmacol. 2014 Feb 1;87(3):399-409. doi: 10.1016/j.bcp.2013.10.025.